Form EFFECT Semnur Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 18, 2026 |
| Accession Number: | 0001193125-26-219654 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bluerock Value Exchange Fully Subscribes $60 Million Diversified Industrial Portfolio 7 DST
- DelphX Announces Closing of Non-Brokered Unit Private Placement
- PAC Machinery & MSD Sales Partner to Showcase Integrated Robotic Kitting and Automatic Bagging Solution at PACK EXPO
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
